US 8987303
AMPK-activating heterocyclic compounds and methods for using the same
granted A61PA61P1/04A61P1/14
Quick answer
US patent 8987303 (AMPK-activating heterocyclic compounds and methods for using the same) held by Rigel Pharmaceuticals, Inc. expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P1/04, A61P1/14, A61P1/16, A61P1/18